Naperville, IL -- (SBWIRE) -- 03/17/2015 -- Reportstack, provider of premium market research reports announces the addition of MediPoint: Nuclear Imaging - Current and Future Players market report to its offering

MediPoint: Nuclear Imaging - Current and Future Players

Summary

This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets. PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report PET imaging uses Positron Emitting radioactive tracers with a short half life, to image metabolically active organs PET combined with CT allows precise anatomical imaging of the body, identifying diseased areas depending upon the tracer used PET/CT is most often used for cancer diagnosis PET/MRI is a new technique that was introduced to reduce patient exposure to radiation PET only systems are now generally considered obsolete, due to the superior imaging quality of PET/CT

The nuclear imaging market is a mature yet dynamic market with several players competing for market share. The competitive landscape consists of large, mid-size, and small companies that are involved in the manufacture and distribution of nuclear imaging systems. Three companies - GE Healthcare, Philips Healthcare, and Siemens Healthcare - dominate the market in all geographies. The remaining smaller companies are either regional companies that are struggling to compete with the multinational companies by offering general imaging equipment, or small companies producing specialist nuclear imaging systems aimed at diagnosing diseases in specific parts of the body. The major players are profiled in the upcoming section, which underlines their current product offerings and strategic initiatives.

Scope

- Investigation of current and future market competition for Nuclear Imaging.

- Competitor assessment including device approval analysis.

- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.

- Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Nuclear Imaging in clinical practice.

Reasons to buy

- Gain a high level view of the trends shaping and driving the Nuclear Imaging market.

- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape

- Take a comprehensive look at the markets device pipeline and identify promising, paradigm-shifting products.

- Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Companies Mentioned

DDD-Diagnostic
Digirad
GE Healthcare
GVI Medical Devices
Mediso Medical Imaging Systems
NeuroLogica
Neusoft Medical Systems
NuCare Medical Systems
Oncovision
Philips Healthcare
Shimadzu
Siemens Healthcare
SurgicEye
Toshiba Medical

Complete report is available
http://www.reportstack.com/product/194763/medipoint-nuclear-imaging-current-and-future-players.html

Contact:
Roger Campbell
roger@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604